Your session is about to expire
← Back to Search
Lorcaserin for Obesity
Study Summary
This trial will investigate the effect of lorcaserin on the brain's control of appetite and metabolism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there vacancies available for participants in this experiment?
"Per the records available on clinicaltrials.gov, this medical research is not presently recruiting participants. Initially posted on October 1st 2014, it was most recently updated on February 28th 2022. However, there are 1071 other trials actively seeking patients at this time."
Does the trial accept participants over 45 years of age?
"This study is seeking patients between the ages of 18 and 65. Separately, 210 trials are available for minors under the age of consent, while 691 clinical studies exist for seniors over 65 years old."
To whom does the eligibility for this clinical experiment extend?
"Eligibility requirements for this medical trial include being of age between 18 and 65, as well as displaying signs of weight loss. Approximately 40 people are needed for recruitment purposes."
What other research projects have focused on the effects of Active?
"Currently, there are 3 operational trials for Active with 1 in Phase 3. Numerous of these research studies take place within Boston, Massachusetts; however, a total 43 sites scattered across the country have been established to conduct clinical trials involving Active."
What is the uppermost limit of patients being included in this clinical study?
"Unfortunately, this medical trial is not currently taking applications. The study was initially posted on October 1st 2014 and last updated on February 28th 2022- if you are searching for alternative studies, 1068 trials related to weight loss and 3 associated with activity are actively recruiting participants."
What perils could individuals using Active possibly encounter?
"There is ample evidence supporting the safety of Active, so it was awarded a 3 rating on our risk scale. This medication has already been approved for public use due to its extensive studies and trials."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger